[HTML][HTML] Cissampelos pareira Linn: Natural Source of Potent Antiviral Activity against All Four Dengue Virus Serotypes

…, TK Barman, S Singhal, RK Shirumalla… - PLoS neglected …, 2015 - journals.plos.org
Background Dengue, a mosquito-borne viral disease, poses a significant global public health
risk. In tropical countries such as India where periodic dengue outbreaks can be correlated …

Antidiabetic activity of resveratrol, a known SIRT1 activator in a genetic model for type‐2 diabetes

…, S Roy, V Shah, JA Davis, RK Shirumalla… - Phytotherapy …, 2011 - Wiley Online Library
In the present study, resveratrol, a polyphenolic SIRT1 activator was evaluated for its SIRT1
activation in an in vitro fluorescent based assay (EC 50 : 7 μM). The efficacy of resveratrol …

Emerging trends in IRAK-4 kinase research

H Yadav, RK Shirumalla - Molecular Biology Reports, 2023 - Springer
The IRAK-4 kinase lies at a critical signaling node that drives cancer cell survival through
multiple mechanisms, activation, and translocation of NF-κB mediated inflammatory responses …

Pharmacology of a novel, orally active PDE4 inhibitor

SG Dastidar, A Ray, R Shirumalla, D Rajagopal… - Pharmacology, 2009 - karger.com
Background: Intracellular cyclic adenosine monophosphate (cAMP) in inflammatory cells
and airway smooth muscle is critical to the modulation of inflammatory response generation. …

Pharmacological profile of AW-814141, a novel, potent, selective and orally active inhibitor of p38 MAP kinase

…, M Chatterjee, T Chaira, RK Shirumalla… - International …, 2010 - Elsevier
The p38 mitogen activated protein kinase (MAPK) is a key signaling molecule that plays a
crucial role in the progression of various inflammatory diseases such as rheumatoid arthritis (…

[PDF][PDF] Ceramide kinase: a potential anti-inflammatory target?

S Saxena, M Banerjee, RK Shirumalla… - Current Opinion in …, 2008 - researchgate.net
Ceramide 1-phosphate (C1P) possesses emerging and diversified roles in the regulation of
various physiological and pathological processes, including cell proliferation, apoptosis and …

2-{N-[(2, 4, 5-trichlorophenoxy) acetyl]-N-methylamino}-3-pyrrolidinepropanamide analogs as potential antagonists of Urotensin II receptor

…, SK Singh, S Sinha, RK Shirumalla… - Journal of Receptors …, 2023 - Taylor & Francis
The purpose of the article To identify novel small molecule antagonists of Urotensin II
receptor with acceptable pharmacological profile. Materials and methods Structure-activity-…

Developing selective FPR2 agonists can be a potential approach to treat moderate to severe asthma

…, R Kumar, M Bandgar, N Karanjule, RK Shirumalla… - bioRxiv, 2021 - biorxiv.org
Formyl peptide receptor (FPR) family members have been reported to play important role in
the resolution of inflammation. A few FPR2/FPR1 dual agonists are reported in the public …

Efficacy of a novel PI3Kd inhibitor, DS-1515 in animal models of asthma

…, S Sinha, SK Singh, H Kalonia, S Wagh, R Shirumalla… - 2018 - Eur Respiratory Soc
Introduction: Therapies that abrogate eosinophilic airway inflammation are beneficial in
treatment of asthma. PI3K delta, a class IA PI3 kinase is integral in the orchestration of both …

[CITATION][C] Evaluation of Topical Formulations of Selective Cyclooxygenase 2 COX 2 Inhibitors for Analgesic and Anti inflammatory Efficacy as well as Plasma …

RK Shirumalla - shodhganga.inflibnet.ac.in
Shodhganga@INFLIBNET: Evaluation of Topical Formulations of Selective Cyclooxygenase 2
COX 2 Inhibitors for Analgesic and Anti inflammatory Efficacy as well as Plasma Concentration …